dataService

您的位置: 首页 > 数据服务 > 数据列表页

筛选

共检索到36条 ,权限内显示50条;

Data from: A curated and standardized adverse drug event resource to accelerate drug safety research
负责人:
关键词:
Drug Safety;Adverse Drug Events;pharmacovigilance
DOI:
doi:10.5061/dryad.8q0s4
摘要:
Identification of adverse drug reactions (ADRs) during the post-marketing phase is one of the most important goals of drug safety surveillance
Data from: A dataset quantifying polypharmacy in the United States
负责人:
关键词:
observational health data;polypharmacy
DOI:
doi:10.5061/dryad.sm847
摘要:
summary of polypharmacy in a large US cohort, which can prioritize common drug combinations for future safety and efficacy studies.
Data from: Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis
负责人:
关键词:
Health policy;Health economics;2003-2017;Organisation of health services
DOI:
doi:10.5061/dryad.tv138
摘要:
and safety of the drug-indication at the time the recommendation was made.
Data from: Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry
负责人:
关键词:
Adverse events;Clinical Trials;Health & safety
DOI:
doi:10.5061/dryad.3t6sc
摘要:
Objective: Phase IV trials are often used to investigate drug safety after approval. However, little is known about the characteristics
Data from: Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children
负责人:
关键词:
Xenobiotic Metabolizing Enzymes;human;Hepatic;Cytochrome P450;Sulfotransferase;Glutathione S-Transferase;Flavin Monooxygenase;UDP Glucuronosyltransferase;Homo Sapiens;ontogeny
DOI:
doi:10.5061/dryad.71pp6
摘要:
factors. Thus, a major challenge in applying pharmacogenomics to improve pediatric drug safety is determining at what age functional genetic variants identified in adults
Data from: Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study
负责人:
关键词:
small molecule;Health policy;Adverse events;biologics;therapeutic potential;Clinical pharmacology;Drug Safety;Clinical pharmacology
DOI:
doi:10.5061/dryad.fg679
摘要:
the probability of acquiring a postmarket safety warning in Canada in four different groups of drugs: (1) traditional medications versus biologics; (2) medications
A study of consumer's attitude toward buying skin care product through drug stores in Thailand
负责人:
James G. Hutton, Advisor
关键词:
Skin care product Drug store Buying decision factors Consumer behavior Consumers\u2019 attitude
DOI:
doi:10.14457/tu.the.2015.893
摘要:
covered both exploratory and descriptive research. The samples were people age between 25 \u2013 45 years old who bought skin care product through drug
Data from: Predicting drug-induced liver injury using ensemble learning methods and molecular fingerprints
负责人:
关键词:
DOI:
doi:10.5061/dryad.1k8m6p2
摘要:
Drug-induced liver injury (DILI) is a major safety concern in the drug-development process, and various methods have been proposed to predict
LIM Domain Kinase 1 (LIMK1), Human Kinase Domain; A Target Enabling Package
负责人:
Eidarus Salah;;Beltrami, Alessandra;;Apirat Chaikuad;;Hanke, Thomas;;Kashima, Risa;;Canning, Peter;;Knapp, Susanne Muller;;Knaus, Petra;;Hata, Akiko
关键词:
Structural Genomics Drug Discovery Chemical Biology
DOI:
doi:10.5287/bodleian:zg5naqjyk
摘要:
that may potentially allow the development of a safe drug for this chronic indication.
Data from: Compromised external validity: federally produced cannabis does not reflect legal markets
负责人:
关键词:
Chemical Biology;Health care;Neuroscience;Cannabis sativa;plant sciences;Drug Safety
DOI:
doi:10.5061/dryad.ms343
摘要:
of variability in psychological and physiological effects of Cannabis varieties is essential. The National Institute on Drug Abuse (NIDA) is designated as the sole

首页上一页1234下一页尾页

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充